Neurogene (NGNE) Capital Leases (2015 - 2026)

Neurogene (NGNE) has 12 years of Capital Leases data on file, last reported at $4000.0 in Q1 2026.

• Quarterly Capital Leases fell 76.47% year-over-year to $4000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4000.0 (down 76.47% YoY) and the FY2025 annual result came in at $5000.0, down 80.77% from the prior year.
• Capital Leases fell to $4000.0 in Q1 2026, from $5000.0 in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $66000.0 in Q1 2022 to a low of $4000.0 in Q1 2026.
• A 5-year average of $26294.1 and a median of $10000.0 in 2022 frame the typical range for Capital Leases.
• Annual changes were most pronounced in 2023 — Capital Leases sank 89.39% — and 2024, when it jumped 783.33%.
• Tracing NGNE's Capital Leases over 5 years: stood at $66000.0 in 2022, then dropped by 1.52% to $65000.0 in 2023, then slumped by 60.0% to $26000.0 in 2024, then plunged by 80.77% to $5000.0 in 2025, then slipped by 20.0% to $4000.0 in 2026.
• The last three Capital Leases figures came in at $4000.0 (Q1 2026), $5000.0 (Q4 2025), and $7000.0 (Q3 2025), per Business Quant data.